HomeCompareLNDC vs ARCC

LNDC vs ARCC: Dividend Comparison 2026

LNDC yields 22.83% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LNDC wins by $62.2K in total portfolio value
10 years
LNDC
LNDC
● Live price
22.83%
Share price
$8.76
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$86.7K
Annual income
$9,019.88
Full LNDC calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — LNDC vs ARCC

📍 LNDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLNDCARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LNDC + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LNDC pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LNDC
Annual income on $10K today (after 15% tax)
$1,940.64/yr
After 10yr DRIP, annual income (after tax)
$7,666.90/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, LNDC beats the other by $7,665.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LNDC + ARCC for your $10,000?

LNDC: 50%ARCC: 50%
100% ARCC50/50100% LNDC
Portfolio after 10yr
$55.6K
Annual income
$4,510.52/yr
Blended yield
8.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

LNDC
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$13.00
+48.4% upside vs current
Range: $13.00 — $13.00
Altman Z
0.1
Piotroski
5/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LNDC buys
0
ARCC buys
0
No recent congressional trades found for LNDC or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLNDCARCC
Forward yield22.83%10.82%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$86.7K$24.5K
Annual income after 10y$9,019.88$1.16
Total dividends collected$52.7K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy
Analyst price target$13.00$21.88

Year-by-year: LNDC vs ARCC ($10,000, DRIP)

YearLNDC PortfolioLNDC Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$12,983$2,283.11$11,381$541.15+$1.6KLNDC
2$16,662$2,770.26$12,621$284.08+$4.0KLNDC
3$21,151$3,322.69$13,827$145.31+$7.3KLNDC
4$26,574$3,941.94$15,062$73.43+$11.5KLNDC
5$33,062$4,628.54$16,364$36.89+$16.7KLNDC
6$40,759$5,381.98$17,757$18.49+$23.0KLNDC
7$49,813$6,200.76$19,258$9.25+$30.6KLNDC
8$60,382$7,082.38$20,880$4.63+$39.5KLNDC
9$72,632$8,023.48$22,636$2.32+$50.0KLNDC
10$86,736$9,019.88$24,539$1.16+$62.2KLNDC

LNDC vs ARCC: Complete Analysis 2026

LNDCStock

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.

Full LNDC Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this LNDC vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LNDC vs SCHDLNDC vs JEPILNDC vs OLNDC vs KOLNDC vs MAINLNDC vs HTGCLNDC vs GBDCLNDC vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.